Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
From the clinicoeconomic viewpoints the treatment of community-acquired pneumonia in patients without risk factors under hospital conditions with aminopenicillins was more appropriate, whereas for the treatment of patients with risk factors the following scheme of antibiotic therapy was advantageous...
Saved in:
Main Authors: | O. V. Molchanova, S. SH. Suleimanov, A. B. Ostrovsky |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC "Publishing House OKI"
2020-05-01
|
Series: | Антибиотики и Химиотерапия |
Subjects: | |
Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/240 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01) -
Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01) -
Optimizing antibiotic therapy of group IV community-acquired pneumonia patients.
by: Ya. O. Dziublyk
Published: (2014-06-01) -
Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia
by: A. A. Taube, et al.
Published: (2023-11-01) -
Evaluation of the Effect of Comorbidity on the Efficacy and Safety of β-Lactam Antibiotics in Patients with Community-Acquired Pneumonia
by: O. V. Muslimova, et al.
Published: (2022-07-01)